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Infections in orthopedic surgery are a serious issue. Antibiotic-loaded bone
cement was developed (FDA Approved) for the treatment of infected joint
arthroplasties and for prophylaxis in total joint replacement. Bone cement
is composed of poly-methyl-methacrylate (PMMA) or copolymers, is a
polymeric material commonly used for the fixation of the joint implants
to the bone. The mechanism by which antibiotic elutes from PMMA is
not fully understood but generally is thought to be a passive phenomenon
in which antibiotic diffuses out of pores, cracks, and voids in the cement.
Most studies evaluating combinations of antibiotics have demonstrated a
synergistic effect, in that adding a second antibiotic seems to increase the
elution of both antibiotics.1, 2, 3
Characteristic of the Antibiotic: Antibiotic must;



		

		

		

have powder preparation
reduce interference with the mechanical properties of the cement.
have broad antibacterial spectrum (including gram positive and
gram negative bacteria), low percentage of resistant species,
be heat stable and hydrophilic nature, Good tissue/bone
penetration and elution from cement.
provide a local concentration able to overcome the “break point
sensitivity limit” of pathogens.4,5

Common Antibiotic used for Cement Bone:
Many antibiotics have been shown to maintain efficacy when mixed with
PMMA. The most commonly used antibiotics and their dosage is listed in table
01. 5,6
Table 1:

Usual Dose for Cement Beads

Antibiotic
Gentamicin

Commercially available with cement ( each 40gm contains
1.0 M.I.U of Gentamicin)

Vancomycin

2gm - 4gm

Piperacillin/
tazobactam

9gm

Meropenem

2gm – 4gm

Colistin

9 M.I.U

Cefazolin

2gm – 4gm

Teicoplanin

2 gm
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FDA Safety Alerts 2016 & 2017
Dr Afia Rais, Trainee Pharmacist

Drug/Class

Safety Update

Month

2017
Tramadol &
Codeine

April

n

FDA restricts use of prescription codeine (children younger than 12 years) pain and 		
cough medicines and tramadol (children younger than 18 years) pain medicines in 		
children; recommends against use in breastfeeding women.

Note: AKUH Karachi does not have codeine preparation but tramadol is available as our formularly drug.

2016
Opioids

March

n
n

Concomitant administration of opioids and antidepressant can result in serotonin
syndrome, in which high levels of the chemical serotonin build up in the brain and
cause toxicity.
Taking opioids may lead to decreased production of adrenal hormone cortisol which
produce symptoms such as nausea, vomiting, loss of appetite, fatigue, dizziness, or
low blood pressure.

Metformin
containing drugs

April

n

Metformin can be used safely in patients with mild impairment in kidney function and
in some patients with moderate impairment in kidney function.

Fluconazole

April

n

Caution is advised for prescribing oral fluconazole in pregnancy as there is a possible
increased risk of miscarriage.

Aripiprazole

May

n

Aripiprazole use is associated with compulsive behaviors and uncontrollable urges 		
such as gamble, binge eat, shop, and sexual activities.

Olanzapine

May

n

Olanzapine can cause a rare and serious skin reaction called DRESS (Drug Reaction 		
with Eosinophilia and Systemic Symptoms) which results in rash, fever and swollen 		
lymph nodes, swollen face, organ injury, and can even lead to death.

Fluoroquinolones

May

n

Fluoroquinolones should be reserved for final treatment options because it can cause 		
disabling and potentially permanent serious side effects involving the tendons, 		
muscles, joints, nerves, and central nervous system.

Ketoconazole

May

n

Prescribing of ketoconazole oral tablets for unapproved uses (skin and nail fungal \
infections) is outweighed by risk of serious liver damage, adrenal gland problems, and
harmful drug interactions.

Sumatriptan

June

n

Use of sumatriptan transdermal patch for migraine headaches can cause serious burns
and potential permanent scarring, severe redness, pain, skin discoloration, blistering,
and cracked skin.
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Drug/Class

Safety Update

Month

Loperamide

June

n

Taking higher than recommended doses of loperamide can cause serious heart
problems, QT interval prolongation, Torsades de Pointes or other ventricular
arrhythmias, syncope, and cardiac arrest and can lead to death.

Opioids with
benzodiazepines

August

n

Combined use of opioid medicines with benzodiazepines or other CNS depressant 		
may result in serious side effects, including slowed or difficult breathing and deaths.

Testosterone

October

n

Abuse of testosterone and other anabolic androgenic steroids at higher doses can affect
the heart, brain, liver, mental health, and endocrine system and cause withdrawal
symptoms.

Pioglitazone

December

n

Use of the antidiabetic medicine pioglitazone may be linked to an increased risk of 		
bladder cancer and should not be used in patients with active bladder cancer.

General anesthetic
and sedation drugs

December

n

Repeated or prolong use of general anesthetic and sedation drugs during surgeries in
children younger than 3 years or in pregnant women during their third trimester may 		
affect the development of children brains.

BupropionDrug/Cl

DecemberM

n

The risk of serious side effects on mood, behavior, or thinking with bupropion is lower
than previously suspected and the benefits outweigh the risks of these medicines for
smoking cessation.

Reference:
www.fda.gov/Drugs/DrugSafety

Antimicrobials Induced Mental Changes
Dr Kashif Hussain, Specialist, Infectious Disease

Antimicrobial Class

Most Common Presentation
of Neurotoxicity

Risk Factors

Fluoroquinolones

Acute psychosis, Confusion,
Delirium, Hallucinations, Mania

Age (possibly)

Cephalosporin: Most
common: cefepime,
ceftazidime, cefazolin

Confusion, Delirium, NCSE
Seizures

Age, Preexisting neurologic
disease, Renal impairment/improper dose for patients
creatinine clearance

Penicillins: Most common: piperacillin/ tazobactam

Bizarre behavior, Confusion,
Delirium, Disorientation
Hallucinations NCSE Seizures

Age, Preexisting neurologic
disease. Renal impairment (especially Crcl<15mL/min)
and/or dialysis

Carbapenems: Most
common: imipenem,
ertapenem

Cognitive impairment, Delirium,
Hallucinations,Psychosis syndrome
Seizures

Age, Preexisting neurologic disease, Renal impairment

Macrolides: Most
common: clarithromycin,
erythromycin

Acute psychosis, Delirium, Mania

Age , Cytochrome P450 3A4 substrates

Sulfonamides: Most
common: TMP/SMX

Acute psychosis, Aseptic meningitis, Hallucinations

Age (especially in HIV-infected patients) Dose Renal
impairment

Amebicide: Most
common Metronidazole

Agitation, Altered mental status,
Cerebellar dysfunction,
Encephalopathy,Ototoxicity,

Cumulative exposure
Use in combination with disulfiram
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Antimicrobial Class

Most Common Presentation
of Neurotoxicity

Risk Factors

Peripheral neuropathy, Psychosis
Seizures
Oxazolidinones: Most
common: Linezolid

Delirium, Encephalopathy,
Peripheral neuropathy,
Serotonin syndrome.

Age, Alcohol abuse, Concomitant, serotonergic drugs.
Diabetes, Preexisting neurologic disease.

Antifungals:
Most common: Voriconazole Azole

Delirium, Hallucinations

Serum Voriconazole concentration >5.5 µg/mL

Antiviral: Most common
Acyclovir

Confusion, Impaired,
consciousness

Dose, Renal impairment

Antiviral: Most common
Oseltamivir

Anxiety, Behavioral change,
Delirium, Delusions, Convulsions,
Encephalitis, Sleep disturbances
Suicidal ideation

Age , Genetic differences (possibly)

Antiviral: Amantadine
and Rimantadine

Anxiety, Behavioral change,
Delirium
Hallucinations, Nervousness

Age, Psychiatric disorder, Renal impairment Seizure disorder

Reference:
1. Bhattacharyya S, Darby RR, Raibagkar P, Gonzalez Castro LN, Berkowitz AL. Antibiotic-associated encephalopathy. Neurology. 2016;
86:963-971.
2. Mattappalil A, Mergenhagen KA. Neurotoxicity with antimicrobials in the elderly: a review. Clin Ther. 2014; 36:1489-1503.
3. Fugate JE, Kalimullah EA, Hocker SE, Clark SL, Wijdicks EF, Rabinstein AA. Cefepime neurotoxicity in the intensive care unit: a cause of
severe, underappreciated encephalopathy. Crit Care. 2013; 17:R264.
4. Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol. 2011;
72:381-393.

Drug Induced Osteoporosis and Role of Pharmacists
Zainab Qadri, Trainee Pharmacist

Osteoporosis is a disease characterized by low bone mineral density and deterioration of the bone architecture
leading to increased fragility and fractures. Osteoporosis may be disease induced hypogonadism (low levels
of testosterone), alcohol abuse, smoking, gastrointestinal disease, hypercalciuria, and immobilization or drug
induced. Drug-induced includes: 1
a) Glucocorticoid Induced Osteoporosis (GIOP) – (for e.g. Prednisolone)
b) Hormonal Therapies:
1. Aromatase inhibitors (AI) - (for e.g. Anastrazole , Letrozole)
2. Gonadotropin releasing hormone(GnRH) agonist - (for e.g. Goserelin, Leuprolide)
3. Depomedroxyprogesterone acetate (DMPA)
4. Thyroid replacement therapy
c) Central nervous system agents:
1. Anticonvulsants -( for e.g. Carbamazepine, Phenobarbital And Phenytoin)
2. Antidepressants - (for e.g. SSRI’s, TCAs)
3. Antipsychotics- (for e.g. Haloperidol)
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d) Gastric Acid Reducing Agents:
1. Proton pump inhibitors - (for e.g. Omeprazole, Esomeprazole etc)
Pharmacists are in a unique position to help reduce the burden of osteoporosis by improving the identification
of high-risk patients for treatment, especially those on corticosteroid therapy.1 Community pharmacies provide
an ideal setting for osteoporosis risk assessment, patient screening and interventions.2 Pharmacists should be
familiar with drugs suspected of causing drug related osteoporosis, risk of fracture associated with specific
agents and patients taking such drugs. Several studies1,2,3,4 suggest that pharmacist identification and counseling of patients at risk for osteoporosis help in reduction of disease.
References:
1. O’Connell MB, Vondracek SF, Osteoporosis and other metabolic bone diseases. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells
		
BG, Posey LM eds.
		
Pharmacotherapy: A pathophysiologic Approach, 7th ed, New York: Mc Graw Hill Medical, 2008 [12]:1483-504
2. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–543.
3. Jones EJ, Mackinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmaco
		
ther. 2005;39:1527–1533. DOI: 10.1345/aph.1E456.
4. Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT. Community pharmacist-initiated screening program for osteoporosis: randomized
		
controlled trial. Osteoporos Int. 2010;21:391–398.

Parenteral Applications of Ketogenic Diet Therapy
Kanwal Saleem, Pharmacist

The ketogenic diet is a well-accepted treatment modality for children with intractable epilepsy and for inborn
errors of carbohydrate metabolism. These children, just as any other child, may be faced with short-term or
long-term medical conditions that require parenteral nutrition (PN)1. Ketogenic diet therapy is a high fat, low
carbohydrate and moderate protein regimen that results in a sustained metabolic state of ketosis.1, 2, 3 Some
clinical studies of ketogenic diet proved that patients who are on ketogenic diet showed an increased GABA
levels in the cerebrospinal fluid, eventually decrease the seizure threshold.
Ketogenic Parenteral nutrition: This nutrition conventionally consists of intravenous fat emulsion plus dextrose and amino acid in hyperalimentation, infused during a bowel rest.
Parameters before Initiation of Therapy:
123		

Monitor for hypoglycemia, hydration, ketosis, seizure response & carbohydrate intake.
Verify that all medications/fluids/supplements are carbohydrate free.
The administration of Carnitine should be considered along with a high-fat or ketogenic TPN
solution. Carnitine facilitates the transport of fatty acids from long chain fats into the mitochondria.

The macronutrient contents of typical Parenteral Nutrition (PN) solution are; 50% to 60% carbohydrate, 10%
to 20% amino acids, and 20% to 30% fat whereas the ratios of these macronutrients in ketogenic parenteral
nutrition are as
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Energy Distribution in ketogenic & regular parenteral Nutrition
Table 01: Energy Distribution of Diet

Ratio
Gms of lipid : gms
of protein &
carbohydrate

4:1

3:1

2:1

1:1

Regular PN

Lipid

90 %

87 %

80 %

70 %

20-30 %

Protein &
Carbohydrate
( non –lipid )

10 %

13 %

20 %

30%

Protein 10 to 20 %
Carbohydrates
50-60%

Due to lack of published literature on this matter, case studies and further investigational studies are required
to develop evidence-based best practice guidelines and more thoroughly evaluate the safety of long-term ketogenic PN.1
References:
1.
2.
3.

Roan M. Management of long-term ketogenic parenteral nutrition. ICAN: Infant, Child, & Adolescent Nutrition. 2011 Oct; 3(5):282-7.
Zupec-Kania BA, Aldaz V, Montgomery ME, Kostas KC. Enteral and parenteral applications of ketogenic diet therapy: Experiences from
four centers. ICAN: Infant, Child, & Adolescent Nutrition. 2011 Oct; 3(5):274-81.
Acton, Q.Ashton PhD, Brain diseases-advances in research and applications: 2013 edition.

4.

McNally MA, Hartman AL. Ketone bodies in epilepsy. Journal of neurochemistry. 2012 Apr 1; 121(1):28-35.

Provide us your Valuable Feedback!

To keep the Pharmacy Newsletter of Aga Khan University Hospital (AKUH) updated we would like to take your valuable feedback. We are grateful
to you for sparing few minutes of your precious time to complete form by below online link or form can be emailed to you as well. Just drop us an
email with subject Newsletter Feedback. Email us at:drug.information@aku.edu
Thank you in advance for your feedback!
Link:
https://goo.gl/forms/Ghh1Nc2KY2jEkiUL2

The Aga Khan University Hospital, Karachi

